These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 8087933

  • 1. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP, Melkert R, Serruys PW.
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [Abstract] [Full Text] [Related]

  • 2. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP, Melkert R, Umans VA, de Jaegere PP, Strikwerda S, de Feyter PJ, Serruys PW.
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ, Hermans WR, Vos J, Tijssen JG, Rutch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serruys PW.
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [Abstract] [Full Text] [Related]

  • 5. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG, Melkert R, Serruys PW.
    Circulation; 1995 Apr 15; 91(8):2140-50. PubMed ID: 7697842
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M, Serruys PW.
    Am J Cardiol; 1994 May 26; 73(14):50D-61D. PubMed ID: 8198025
    [Abstract] [Full Text] [Related]

  • 8. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR, Rensing BJ, Foley DP, Tijssen JG, Rutsch W, Emanuelsson H, Danchin N, Wijns W, Chappuis F, Serruys PW.
    J Cardiovasc Pharmacol; 1993 May 26; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR, Foley DP, Rensing BJ, Serruys PW.
    Am Heart J; 1994 Mar 26; 127(3):483-94. PubMed ID: 8122593
    [Abstract] [Full Text] [Related]

  • 11. Six-month clinical and angiographic outcome of the new, less shortening Wallstent in native coronary arteries.
    Ozaki Y, Keane D, Ruygrok P, van der Giessen WJ, de Feyter P, Serruys PW.
    Circulation; 1996 Jun 15; 93(12):2114-20. PubMed ID: 8925579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Short- and long-term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study.
    Ozaki Y, Violaris AG, Hamburger J, Melkert R, Foley D, Keane D, de Feyter P, Serruys PW.
    J Am Coll Cardiol; 1996 Aug 15; 28(2):354-60. PubMed ID: 8800109
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.
    Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG, Laramee L, Barbeau G, Traboulsi M, Corbett BN.
    N Engl J Med; 1993 Jul 22; 329(4):228-33. PubMed ID: 8316267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Late coronary artery stenosis regression within the Gianturco-Roubin intracoronary stent.
    Hermiller JB, Fry ET, Peters TF, Orr CM, Van Tassel J, Waller B, Pinkerton CA.
    Am J Cardiol; 1996 Feb 01; 77(4):247-51. PubMed ID: 8607402
    [Abstract] [Full Text] [Related]

  • 20. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C, Khanoyan P, McFadden EP, Quandalle P, Lablanche JM, Bertrand ME.
    Circulation; 1995 Mar 01; 91(5):1410-8. PubMed ID: 7867181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.